FDA OKs Voluven for post-op blood loss

December 28, 2007

The U.S. Food and Drug Administration has approved Voluven as a treatment for blood loss after surgery.

Voluven is an intravenous solution that expands blood volume, the agency said Thursday in a release.

Significant blood loss can cause a rapid drop in the volume of red blood cells and plasma circulating through the body. This can lead to shock, which is potentially fatal.

Blood volume expanders are commonly administered to restore quickly some of the lost volume so remaining red blood cells can continue to deliver needed oxygen to the body's tissues, the FDA said.

Voluven, made by the German-firm Fresenius Kabi, contains a synthetic starch that does not dissolve in water. It was found in clinical trials to be as safe and effective as other blood volume expanders, the agency said.

The most common side effects from Voluven were nausea and itching.

Copyright 2007 by United Press International

Related Stories

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.